Uveitis, glaucoma, and cataract with mevalonate kinase deficiency

J AAPOS. 2022 Apr;26(2):93-95. doi: 10.1016/j.jaapos.2021.11.009. Epub 2022 Feb 11.

Abstract

We report 7 years of follow-up data on ocular findings in a 2-month-old boy who presented with early-onset bilateral granulomatous panuveitis with subsequent development of secondary glaucoma and total cataract, along with multisystem involvement. He was diagnosed with mevalonate kinase deficiency (MKD), with a homozygous missense variant in exon-6 of the mevalonate kinase (MVK) gene on chromosome-12 that resulted in the substitution of aspartic acid for asparagine at codon 205 (p.Asn205Asp). Despite being managed with topical/systemic steroids and immunosuppression therapy with methotrexate and a short course of adalimumab, the patient continued to develop recurrent episodes of uveitis along with multisystem manifestations. The occurrence of early-onset uveitis is rare, as is the diagnosis of MKD.

Publication types

  • Case Reports

MeSH terms

  • Adalimumab
  • Cataract* / complications
  • Cataract* / etiology
  • Glaucoma* / complications
  • Humans
  • Infant
  • Male
  • Mevalonate Kinase Deficiency* / complications
  • Mevalonate Kinase Deficiency* / diagnosis
  • Mevalonate Kinase Deficiency* / drug therapy
  • Uveitis* / diagnosis
  • Uveitis* / drug therapy
  • Uveitis* / etiology

Substances

  • Adalimumab